Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Bilateral ESP Catheter After Open Cardiac Surgery
NCT03901612Phase 4Withdrawn
- Sponsor
- Vinmec Healthcare System
- Start
- Jan 2019
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Vinmec Healthcare System. Primary endpoint: Opioid consumption at 48 hours. Planned start Jan 2019; status: withdrawn.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03901612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03901612.